170 related articles for article (PubMed ID: 28459521)
21. Sphere formation reverses the metastatic and cancer stem cell phenotype of the murine mammary tumour 4T1, independently of the putative cancer stem cell marker Sca-1.
Matilainen H; Yu XW; Tang CW; Berridge MV; McConnell MJ
Cancer Lett; 2012 Oct; 323(1):20-28. PubMed ID: 22459350
[TBL] [Abstract][Full Text] [Related]
22. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.
Ames E; Canter RJ; Grossenbacher SK; Mac S; Chen M; Smith RC; Hagino T; Perez-Cunningham J; Sckisel GD; Urayama S; Monjazeb AM; Fragoso RC; Sayers TJ; Murphy WJ
J Immunol; 2015 Oct; 195(8):4010-9. PubMed ID: 26363055
[TBL] [Abstract][Full Text] [Related]
23. Platelet deficiency in Tpo
Thiele W; Rothley M; Dimmler A; Bugert P; Salomó Coll C; Sleeman JP
Clin Exp Metastasis; 2018 Oct; 35(7):679-689. PubMed ID: 30043083
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
25. In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.
Kim MH; Kim MH; Kim KS; Park MJ; Jeong JH; Park SW; Ji YH; Kim KI; Lee TS; Ryu PY; Kang JH; Lee YJ
Int J Oncol; 2016 Jun; 48(6):2277-86. PubMed ID: 27098303
[TBL] [Abstract][Full Text] [Related]
26. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
Lee JC; Lee KM; Kim DW; Heo DS
J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
[TBL] [Abstract][Full Text] [Related]
27. Modulation of natural killer cell anti-tumor reactivity by platelets.
Placke T; Kopp HG; Salih HR
J Innate Immun; 2011; 3(4):374-82. PubMed ID: 21411974
[TBL] [Abstract][Full Text] [Related]
28. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells.
Wang B; Wang Q; Wang Z; Jiang J; Yu SC; Ping YF; Yang J; Xu SL; Ye XZ; Xu C; Yang L; Qian C; Wang JM; Cui YH; Zhang X; Bian XW
Cancer Res; 2014 Oct; 74(20):5746-57. PubMed ID: 25164008
[TBL] [Abstract][Full Text] [Related]
29. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
Orellana R; Kato S; Erices R; Bravo ML; Gonzalez P; Oliva B; Cubillos S; Valdivia A; Ibañez C; Brañes J; Barriga MI; Bravo E; Alonso C; Bustamente E; Castellon E; Hidalgo P; Trigo C; Panes O; Pereira J; Mezzano D; Cuello MA; Owen GI
BMC Cancer; 2015 Apr; 15():290. PubMed ID: 25886038
[TBL] [Abstract][Full Text] [Related]
30. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt B; Hafner M; Echtenacher B; Männel DN
Cancer Res; 1999 Mar; 59(6):1295-300. PubMed ID: 10096562
[TBL] [Abstract][Full Text] [Related]
31. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
32. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells.
Coupland LA; Chong BH; Parish CR
Cancer Res; 2012 Sep; 72(18):4662-71. PubMed ID: 22836751
[TBL] [Abstract][Full Text] [Related]
33. Involvement of platelets in tumor cell metastasis.
Tesfamariam B
Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
[TBL] [Abstract][Full Text] [Related]
34. [Effects of down-regulation of IGF2 gene on the biological characteristics of HCT116 colon cancer stem cells].
Zhao X; Li J; Liu HQ; Liu XL
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):580-586. PubMed ID: 31434448
[No Abstract] [Full Text] [Related]
35. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
Arteaga CL; Koli KM; Dugger TC; Clarke R
J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
[TBL] [Abstract][Full Text] [Related]
36. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
39. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
40. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
Mamessier E; Sylvain A; Bertucci F; Castellano R; Finetti P; Houvenaeghel G; Charaffe-Jaufret E; Birnbaum D; Moretta A; Olive D
Cancer Res; 2011 Nov; 71(21):6621-32. PubMed ID: 21937679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
